Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HUYA Inc. Reports Second Quarter 2021 Unaudited Financial Results 2021-08-17 17:00
NetEase to Report Second Quarter 2021 Financial Results on August 31 2021-08-17 16:30
Haitong International Private Wealth Management Launches Global Family Office Business 2021-08-17 16:06
AiHuiShou International Co. Ltd. Reports Unaudited Second Quarter 2021 Financial Results 2021-08-17 15:10
Dada Group's JDDJ Releases Report: On-demand Consumption of Snack Food 2021-08-17 12:20
Baidu Announces Proposed Debt Offering 2021-08-17 05:34
China HGS Announces First Nine Months of Fiscal 2021 Financial Results 2021-08-17 04:45
Senmiao Technology Reports Fiscal 2022 First Quarter Financial Results 2021-08-17 04:30
Tencent Music Entertainment Group Announces Second Quarter 2021 Unaudited Financial Results 2021-08-17 04:05
Ascletis' Partner Sagimet Dosed First Patient in FASCINATE-2 Phase IIb Trial in NASH Patients with Moderate to Advanced Fibrosis 2021-08-16 21:30
90% enterprises yet to achieve digital-first goals; Cyber security emerges as most critical Tata Communications report shows 2021-08-16 21:19
Shanghai Electric Gives Toys and Gift Packages to Children of Thar Community to Celebrate Eid Al-Adha 2021-08-16 21:10
Verisk Analytics Lauded by Frost & Sullivan for Pioneering Telematics Data Exchange for Usage-Based Insurance in North America 2021-08-16 21:00
Macronix ArmorFlash NOR Flash Earns PSA Certified Level 1 Status 2021-08-16 21:00
RISE Education Provides Update on Quarterly Earnings Release 2021-08-16 20:55
Informa Launches Curinos, A Powerful New Data Engine for Competing Banks 2021-08-16 20:08
RBC invites participants around the world to experience reimagined, virtual Race for the Kids event 2021-08-16 20:05
China Finance Online Announces Private Placement of Ordinary Shares and Warrants 2021-08-16 20:00
Cango Inc. to Report Second Quarter 2021 Financial Results on August 19, 2021 Eastern Time 2021-08-16 20:00
Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen Biopharm to Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 in Solid Tumors 2021-08-16 20:00